Comparison of intra-articular steroid injection with combined oral steroid and intra-articular steroid injection to treat patients with knee osteoarthritis

Farah Mahboob; Sarah  Razzaq; Ijaz  Ahmad; Maimoona  Rashid; Umer  Younus; Syed Hussain  Shah

doi:10.51253/pafmj.v75i1.11526

Authors

Farah Mahboob Department of Rehabilitation Medicine, Combined Military Hospital Kharian /National University of Medical Sciences (NUMS) Pakistan
Sarah Razzaq Department of Rehabilitation Medicine, Combined Military Hospital Mangla /National University of Medical Sciences (NUMS) Pakistan
Ijaz Ahmad Department of Rehabilitation Medicine, Combined Military Hospital Quetta /National University of Medical Sciences (NUMS) Pakistan
Maimoona Rashid Department of Rehabilitation Medicine, Combined Military Hospital Rawalpindi /National University of Medical Sciences (NUMS) Pakistan
Umer Younus Department of Rehabilitation Medicine, Combined Military Hospital Hyderabad /National University of Medical Sciences (NUMS) Pakistan
Syed Hussain Shah Department of Rehabilitation Medicine, Combined Military Hospital Muzzafarabad /National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i1.11526

Keywords:

Methylprednisolone, Osteoarthritis, Prednisolone.

Abstract

Objective: To evaluate the benefits provided by a short course of low dose oral Prednisolone followed by intra-articular injection of Methylprednisolone to treat osteoarthritis Knee as compared to intra-articular injection of Methylprednisolone and placebo.

Study Design: Quasi-experimental study

Place and Duration of Study: Department of Rehabilitation Medicine, Combined Military Hospital Quetta, Pakistan from Aug to Nov 2023.

Methodology: Ninety nine patients with OA of Knee joint were randomly assigned to 3 groups, Group-A received a short course (14 days) of low dose oral steroids (15 mg Prednisolone ) followed by one intra-articular steroid injection (administered two weeks later). Patients in Group-B received intra-articular injection of steroid only and Group-C received intra-articular injection of normal saline. All patients were evaluated using the Western Ontario and McMaster Universities (WOMAC) & Visual Analogue Scale (VAS) score before the treatment and at 2,6,12 and 16 weeks following treatment.

Result: There were significant improvements in both Group-A & Group-B. Particularly, patients in Group-A had significantly superior VAS and WOMAC scores than were seen in groups B and C. The VAS and WOMAC scores remained the same as were pre-treatment in group C. Group-A and B both showed improvement but to different extent with superior results in Group-A till 16 weeks.

Conclusion: The combination of short course of low dose oral steroids with intra-articular steroid injections resulted in significantly superior symptomatic improvement, with sustained lower VAS and WOMAC scores, hence improving quality of life for 16 weeks.

Downloads

Download data is not yet available.

References

Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019; 393(10182): 1745-1759.

https://doi.org/10.1016/s0140-6736(19)30417-9

Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021; 325(6): 568-578.

https://doi.org/10.1001/jama.2020.22171

Su K, Bai Y, Wang J, Zhang H, Liu H, Ma S. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis. Clinical Rheumatol. 2018; 37: 1341-1350.

https://doi.org/10.1007/s10067-018-3985-6

Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022; 18(5): 258-275. https://doi.org/10.1038/s41584-022-00749-9

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;1; 9(6): 7204.https://doi.org/10.18632/oncotarget.23208

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7(1): 33-42.

https://doi.org/10.1038/nrrheum.2010.196

Sabha M, Hochberg MC. Non-surgical management of hip and knee osteoarthritis; comparison of ACR/AF and OARSI 2019 and VA/DoD 2020 guidelines. Osteoarthr Cartil Open. 2021; 4(1): 100232. Published 2021 Dec 25.

https://doi.org/10.1016/j.ocarto.2021.100232

Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. Jama. 2021; 326(20): 2021-2030.

https://doi.org/10.1001/jama.2021.19415

Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and cartilage. 2019; 27(11): 1578-1589.

https://doi.org/10.1016/j.joca.2019.06.011

Cheng OT, Souzdalnitski D, Vrooman B, Cheng J. Evidence-based knee injections for the management of arthritis. Pain Med. 2012; 13(6): 740-753.

https://doi.org/10.1111/j.1526-4637.2012.01394.x

Cai Z, Cui Y, Wang J, Qi X, He P, Bu P, et al. A narrative review of the progress in the treatment of knee osteoarthritis. Ann Trans Med. 2022 ; 10(6) 373.

https://doi.org/10.21037/atm-22-818

Han SB, Seo IW, Shin YS. Intra-articular injections of hyaluronic acid or steroids associated with better outcomes than platelet-rich plasma, adipose mesenchymal stromal cells, or placebo in knee osteoarthritis: a network meta-analysis. Arthroscopy. 2021; 37(1): 292-306.

https://doi.org/10.1016/j.arthro.2020.03.041

Maricar N, Parkes MJ, Callaghan MJ, Felson DT, O’Neill TW. Do clinical correlates of knee osteoarthritis predict outcome of intraarticular steroid injections? J Rheumatol. 20201; 47(3): 431-440.

https://doi.org/10.3899/jrheum.180233

Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J,et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis rheumatol. 2020; 72(2): 220-233.

https://doi.org/10.1002/art.41142

Russell SJ, Sala R, Conaghan PG, Habib G, Vo Q, Manning R, et al.Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study. Rheumatol. 2018; 57(12): 2235-41.

https://doi.org/10.1093/rheumatology/key265

Conaghan G, Hunter J, Cohen B, Kraus B, Berenbaum F, Lieberman JR, Jones DG, Spitzer AI, Jevsevar DS, Katz NP, Burgess DJ. Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain: a double-blinded, randomized, placebo-controlled, multinational study. J Bone Joint Surg Am. 2018 ; 100(8): 666-677.

https://doi.org/10.2106/jbjs.17.00154

McAlindon E, LaValley P, Harvey F, Price L, Driban B, Zhang M, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017; 317(19): 1967-1975.

https://doi.org/10.1001/jama.2017.5283

Deyle D, Allen S, Allison C, Gill W, Hando R, Petersen J, et al. Physical therapy versus glucocorticoid injection for osteoarthritis of the knee. N Engl J Med. 2020; 382(15): 1420-1429.

https://doi.org/10.1056/nejmoa1905877

Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean j intern Med. 2019;34(5):966.

https://doi.org/10.3904/kjim.2018.460

Kroon P, Kortekaas C, Boonen A, Böhringer S, Reijnierse M, Rosendaal R,et al. Results of a 6-week treatment with 10 mg Prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet. 2019; 394(10213): 1993-2001.

https://doi.org/10.1016/s0140-6736(19)32489-4